High serum cytokine levels may predict the responsiveness of patients with severe asthma to benralizumab.
Shizuka WatanabeMaho SuzukawaHiroyuki TashimoNobuharu OhshimaIsao AsariSahoko ImotoNobuyuki KobayashiShigeto TohmaTakahide NagaseKen OhtaPublished in: The Journal of asthma : official journal of the Association for the Care of Asthma (2021)
Low baseline serum inflammatory cytokine levels may be useful in predicting a good benralizumab response.Supplemental data for this article is available online at at www.tandfonline.com/ijas .